THE EFFECT OF DIET THERAPY ON CLINICAL AND LABORATORY PARAMETERS IN CHRONIC HEPATITIS B

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/3291

Full metadata record

DC Field	Value	Language
dc.contributor.author	Turdiyev, U. X.	-
dc.contributor.author	Xurramov, Ch. D.	-
dc.contributor.author	Jalolov, N. N.	-
dc.date.accessioned	2026-04-11T05:13:10Z	-
dc.date.available	2026-04-11T05:13:10Z	-
dc.date.issued	2026-04-06	-
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/3291	-
dc.description.abstract	Chronic hepatitis B (CHB) remains a significant epidemiological and clinical challenge in global healthcare. According to the World Health Organization, more than 250 million people worldwide live with this infection, and approximately 800,000 deaths annually are associated with liver cirrhosis and hepatocellular carcinoma.	en_US
dc.language.iso	en	en_US
dc.publisher	World Conference on Social Sciences, Law and Public Policy	en_US
dc.title	THE EFFECT OF DIET THERAPY ON CLINICAL AND LABORATORY PARAMETERS IN CHRONIC HEPATITIS B	en_US
dc.type	Article	en_US
Appears in Collections:	Articles

Files in This Item:

File	Description	Size	Format
1-999 (9).pdf		354.52 kB	Adobe PDF	View/Open

DSpace JSPUI